CD19 and Alzheimer disease: Similarly, our study demonstrated no statistically significant differences in the expression of positive (CD73, CD90, CD105, CD13) and negative markers (CD14, CD45, CD19, CD31) between AD-MSCs and dermal fibroblasts.